UNITED
STATES SECURITIES AND
EXCHANGE
COMMISSION
Washington,
D.C. 20549
FORM
8-K
CURRENT
REPORT
Pursuant
to Section 13 or 15(d) of the Securities Exchange Act of 1934
Date of
Report (Date of earliest event reported): December 8, 2009
CASCADE
TECHNOLOGIES CORP.
(Exact
name of registrant as specified in its charter)
| Wyoming |
|
333-124284 |
|
98-0440633 |
|
(State
or other jurisdiction of
incorporation)
|
|
(Commission
File
Number)
|
|
(IRS
Employer\ Identification
No.)
|
1530
– 9th Ave
S.E., Calgary,
Alberta T2G
0T7
(Address
of principal executive
offices) (Zip
Code)
(403)
693-8000
Registrant’s
telephone number, including area code
(Former
name or former address, if changed since last report)
Check the
appropriate box below if the Form 8-K filing is intended to simultaneously
satisfy the filing obligation of the registrant under any of the following
provisions (see General Instruction A.2. below):
|
|
¨ Written
communications pursuant to Rule 425 under the Securities Act (17 CFR
230.425)
|
|
|
¨ Soliciting
material pursuant to Rule 14a-12 under the Exchange Act (17 CFR
240.14a-12)
|
|
|
¨ Pre-commencement
communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR
240.14d-2(b))
|
|
|
¨ Pre-commencement
communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR
240.13e-4(c))
|
ITEM
5.02 DEPARTURE OF DIRECTORS OR CERTAIN
OFFICERS; ELECTION OF DIRECTORS; APPOINTMENT OF CERTAIN OFFICERS; COMPENSATORY
ARRANGEMENTS OF CERTAIN OFFICERS
Resignation
of Director and Principal Officer:
On
December 8, 2009, Mr. Dwayne Flett, the President of Cascade Technologies Corp.
(the “Company”), informed the Board of Directors of the Company that he was
resigning as a Director and President of the Company effective
immediately. Mr. Flett did not resign as a result of any disagreement
with the Company on any matter relating to the Company’s operations, policies,
or practices.
Election
of Directors and Principal Officer:
On
December 8, 2009, Dr. Erik Lindsley was appointed to the Board of Directors of
the Company and appointed President of the Company. Dr.
Lindsley will serve as the President with his principal responsibilities
including both business development and product research and development. Dr.
Lindsley currently serves as a Research Scientist in the Minimally Invasive
Surgical Technologies Institute at the Cedars Sinai Medical Center, Los
Angeles—a position he has held since April of 2005. From September 2003 to March
2005, Dr. Lindsley worked as a Post-doctoral Researcher in the Robotics
Institute (Spectral Visualization Lab) at Carnegie Mellon University,
Pittsburgh. Prior to 2003, Dr. Lindsley held various positions in the
bioengineering and high-tech fields, including engagements in research and
consulting. Dr. Lindsley received his B.S. in Computer Science and his M.S. in
Electrical Engineering from the University of Kansas, his Ph.D. in
Bioengineering from the University of Pittsburgh, and he completed his
Post-doctoral work in Bio-Imaging at Carnegie Mellon University.
This
is Dr. Lindsley’s first board position with a reporting issuer. Dr.
Lindsley will serve as the President of the Company and will work closely with
the Company’s Board of Directors and officers in planning our
business development.
SIGNATURES
Pursuant
to the requirements of the Securities Exchange Act of 1934, the registrant has
duly caused this report to be signed on its behalf by the undersigned hereunto
duly authorized.
CASCADE
TECHNOLOGIES CORP.
By: /s/ Jacqueline
Danforth
Name: Jacqueline
Danforth
Title: Secretary, Chief
Financial Officer & Director
Date: December 14,
2009